$Mega Fortune Company Limited(MGRT)$ $Mega Fortune Company Limited(MGRT) Soared +44.92%: Explosive Momentum Tests $30, $31.85 ATH in Sight Latest Close Data Closed at $27.65 on 2026-04-07, surging +44.92% ($8.57). The price is now just $4.20 (-13.2%) below its 52-week high of $31.85. Core Market Drivers The stock experienced massive intraday volatility with a 60.18% amplitude, indicating intense speculative interest. Strong net capital inflow of ~$362K over the past day and a significant $176.7K inflow on 2026-04-06 suggest accumulating bullish pressure, potentially driven by undisclosed corporate developments or sector rotation. Technical Analysis Volume was significant at 243.8K shares. The MACD (DIF: 2.84, DEA: 1.07, MACD: 3.55) shows a powerfu
$Advanced Biomed Inc.(ADVB)$ $Advanced Biomed Inc.(ADVB) Surged +47.51%: High-Velocity Breakout Eyes $7.6, Extreme Volatility Persists Latest Close Data: Closed at $6.52 on 2026-04-07, up a staggering +47.51% (+$2.10). The stock remains significantly below its 52-week high of $57.80 (-88.7%). Core Market Drivers: The massive intraday swing of 35.07% and extreme turnover rate (1096.23%) suggest high speculative activity. No specific company news is highlighted, indicating the move may be driven by technical momentum and high retail interest in low-float stocks. Technical Analysis: The breakout is confirmed by surging volume (19.67x ratio). MACD has turned decisively bullish with DIF crossing above DEA and the histogram positive at 0.336. RSI(6) at
$SILO PHARMA INC.(SILO)$ SILO PHARMA (SILO) Explodes +49.02%: Micro-Cap Biotech Breaks Out on Massive Volume, $0.63 High Reclaimed Latest Close: $0.5302 (+49.02%). The stock closed just 55.4% below its 52-week high of $1.19, marking a significant intraday recovery from the $0.46 low. Core Market Drivers: The surge appears driven by extreme retail speculation and momentum, as no specific company news was reported. The massive 1154% turnover rate and 44.84x volume ratio indicate a classic "meme stock" style short squeeze or pump, likely fueled by social media chatter. Technical Analysis: The 6-day RSI at 87.5 indicates the stock is deeply overbought. The MACD (0.0218) turned positive for the first time in this data series, generating a strong buy si
$Cuprina Holdings (Cayman) Limited(CUPR)$ $Cuprina Holdings (Cayman) Limited (CUPR) Skyrockets +52.39%: Explosive Breakout, Eyeing $0.68-$0.70 Range Latest Close Data: Closed at $0.6015, surging +52.39% on 04/07. Current price is 93.7% below its 52-week high of $9.50. Core Market Drivers: The massive +52% single-day surge appears driven by significant retail buying interest and a potential short squeeze, given the extremely high daily turnover rate of 210.21%. No specific company news was identified, suggesting the move may be technically driven or based on undisclosed catalysts. Technical Analysis: Volume exploded to 45.1M shares (VR=4.51), confirming breakout strength. The RSI(6) at 85.4 signals extreme overbought conditions, warning of a near-t
$LITE Options Short Iron Condor: Credit $810, Max Profit $810 on Apr 8, 2026
$Lumentum(LITE)$ Iron Condor Strategy: cost $1,190, max earn $810 in 9 days — sell elevated IV, delta‑neutral range view 📊 Ticker: $LITE Strategy: Short Iron Condor Contracts: Sell to Open: LITE Apr 17 $820 Call Buy to Open: LITE Apr 17 $840 Call Sell to Open: LITE Apr 17 $800 Put Buy to Open: LITE Apr 17 $780 Put Cost: $810 Max Gain: $810 (100% of premium if stock stays between $800-$820) Max Loss: $1,190 (if stock moves outside the wings) Profit Zone: $800 - $820 Thesis: Neutral to range-bound view on Lumentum into April expiration. Optical components sector showing consolidation after recent volatility. Selling premium on both sides while defining risk outside the expected move—betting the stock stays contained between $780 and $840 through exp
$SNAP Bull Call Spread: $30 Cost, Up to $20 Max Profit by Apr 17, 2026
$Snap Inc(SNAP)$ Options Bull Call Spread: Cost $30, Max Profit $20 on Apr 8, 2026 📊 Ticker: $SNAP Strategy: Bull Call Spread Contracts: Buy to Open: SNAP Apr 17 $4.5 Call Sell to Open: SNAP Apr 17 $5.0 Call Cost: $30 Max Gain: $20 (0.67x return) Max Loss: $30 (100% of premium) Breakeven: $4.80 Thesis: Moderately bullish on Snapchat into April expiration. Social media names have shown resilience, and sub-$5 levels offer an attractive entry for a measured upside play. Low-dollar stock with tight spreads—capturing a move toward $5 while keeping risk defined. If it grinds higher, the spread captures full value. If it stalls, premium is capped. ⚠️ Disclaimer: This is not financial advice. Options trading involves significant risk and may result in los
$CAT Short Iron Condor: Cost $0 (Net Credit $295), Max Profit $295 in 9 Days
$Caterpillar(CAT)$ Options Short Iron Condor: Credit $295, Max Profit $295 on Apr 8, 2026 📊 Ticker: $CAT Strategy: Short Iron Condor Contracts: Sell to Open: CAT Apr 17 $740 Call Buy to Open: CAT Apr 17 $750 Call Sell to Open: CAT Apr 17 $710 Put Buy to Open: CAT Apr 17 $700 Put Cost: $295 Max Gain: $295 (100% of premium if stock stays between $710-$740) Max Loss: $705 (if stock moves outside the wings) Profit Zone: $700 - $710 to $740 - $750 Thesis: Neutral to range-bound view on Caterpillar. Earnings volatility has likely compressed, expecting the stock to chop sideways through April expiration. Collecting premium from both sides while defining risk outside the expected move. Happy if it stays in the middle—max pain is a big breakout in either di
$INTC Bull Call Spread Strategy — Cost $32, Max Profit Up to $200,
$Intel(INTC)$ Options Bull Call Spread: Cost $650, Max Profit $850 on Apr 8, 2026 📊 Ticker: $INTC Strategy: Bull Call Spread Contracts: Buy to Open: INTC Oct 20 $30 Call Sell to Open: INTC Oct 20 $45 Call Cost: $650 Max Gain: $850 (1.3x return) Max Loss: $650 (100% of premium) Breakeven: $36.50 Thesis: Moderately bullish on Intel with a wide spread capturing upside toward $45. Legacy chip maker with foundry ambitions—playing for a sentiment shift while the turnaround narrative plays out. Wide strikes offer attractive risk/reward if momentum builds, with max loss capped if the story fizzles. ⚠️ Disclaimer: This is not financial advice. Options trading involves significant risk and may result in loss of capital. Past performance does not guarantee f
$AVGO Iron Condor Strategy — Cost $190, Max Profit $310 in 2 Days
$Broadcom(AVGO)$ Options Bull Call Spread: Cost $320, Max Profit $180 on Apr 8, 2026 📊 Ticker: $AVGO Strategy: Bull Call Spread Contracts: Buy to Open: AVGO Apr 10 $330 Call Sell to Open: AVGO Apr 10 $335 Call Cost: $320 Max Gain: $180 (0.56x return) Max Loss: $320 (100% of premium) Thesis: Moderately bullish on Broadcom into next week's expiration. AI and data center demand continue to drive semiconductor names. Playing for a move toward $335 with defined risk—if it expires above the short strike, capture the spread width. If it stalls, premium is the tuition. ⚠️ Disclaimer: This is not financial advice. Options trading involves significant risk and may result in loss of capital. Past performance does not guarantee future results. Always do your
$AVGO Iron Condor Strategy — Cost $190, Max Profit $310 in 2 Days
$Broadcom(AVGO)$ Options Bull Call Spread: Cost $320, Max Profit $180 on Apr 8, 2026 📊 Ticker: $AVGO Strategy: Bull Call Spread Contracts: Buy to Open: AVGO Apr 10 $330 Call Sell to Open: AVGO Apr 10 $335 Call Cost: $320 Max Gain: $180 (0.56x return) Max Loss: $320 (100% of premium) Thesis: Moderately bullish on Broadcom into next week's expiration. AI and data center demand continue to drive semiconductor names. Playing for a move toward $335 with defined risk—if it expires above the short strike, capture the spread width. If it stalls, premium is the tuition. ⚠️ Disclaimer: This is not financial advice. Options trading involves significant risk and may result in loss of capital. Past performance does not guarantee future results. Always do your
$CVS Bear Put Spread: $104 Cost, Earn Up to $146 by Apr 17 (9 DTE)
$CVS Health(CVS)$ Options Bear Put Spread: Cost $104, Max Profit $146 on Apr 8, 2026 📊 Ticker: $CVS Strategy: Bear Put Spread (Debit Spread) Contracts: Buy to Open: CVS Apr 17 $77.5 Put Sell to Open: CVS Apr 17 $75 Put Cost: $104 Max Gain: $146 (1.4x return) Max Loss: $104 (100% of premium) Thesis: Mildly bearish on CVS near-term. Healthcare retail facing margin pressures and regulatory headwinds. Defined risk play—if it breaks below $75, the spread maxes out. If wrong, premium lost is capped. ⚠️ Disclaimer: This is not financial advice. Options trading involves significant risk and may result in loss of capital. Past performance does not guarantee future results. Always do your own research and consult a qualified financial advisor before making i
$UNH Options Bull Put Spread: Credit $95, Max Profit $95 on Apr 8, 2026
📊 Ticker: $UnitedHealth(UNH)$ Strategy: Bull Put Spread (Credit Spread) Contracts: Sell to Open: UNH Apr 18 $300 Put Buy to Open: UNH Apr 18 $295 Put Credit: $95 Max Gain: $95 (100% of premium if expires worthless) Max Loss: $405 (strike width minus credit) Thesis: Neutral to moderately bullish on UnitedHealth into April expiration. Selling 2-week premium while defining downside risk. Happy to pocket the credit if stock stays above $300, ready to defend if it doesn't. ⚠️ Disclaimer: This is not financial advice. Options trading involves significant risk and may result in loss of capital. Past performance does not guarantee future results. Always do your own research and consult a qualified financial advisor before making investment decisions.
$NVDA Iron Condor: Cost $167, Max Profit $83 in 2 Days
$NVIDIA(NVDA)$ Options Bull Call Spread: Cost $750, Max Profit $1,250 on Apr 8, 2026 📊 Ticker: $NVDA Strategy: Bull Call Spread Contracts: Buy to Open: NVDA May 17 $900 Call Sell to Open: NVDA May 17 $920 Call Cost: $750 Max Gain: $1,250 (1.67x return) Max Loss: $750 (100% of premium) Breakeven: $907.50 Thesis: Bullish on NVIDIA into May expiration. AI infrastructure demand remains relentless, and this spread captures a move toward $920 while keeping risk defined. Wide strikes offer attractive upside if momentum builds—don't need NVDA to hit new highs, just a grind higher through the summer months. ⚠️ Disclaimer: This is not financial advice. Options trading involves significant risk and may result in loss of capital. Past performance does not gua
$PSKY Options Bull Call Spread: Cost $33, Max Profit $200 on Apr 8, 2026
📊 Ticker: $Paramount Skydance Corp(PSKY)$ Strategy: Short Iron Condor Contracts: Sell to Open: PSKY Apr 17 $11 Call Buy to Open: PSKY Apr 17 $12 Call Sell to Open: PSKY Apr 17 $10 Put Buy to Open: PSKY Apr 17 $9 Put COST : $33 Max Gain: $33 (100% of premium if stock stays between $10-$11) Max Loss: $67 (if stock moves outside the wings) Profit Zone: $10 - $11 Thesis: Neutral to range-bound view on PSKY into April expiration. Expecting the stock to consolidate within the $9-$12 range through expiration. Selling premium on both sides while defining tight risk—ideal for a low-volatility environment where the underlying chops sideways. Max pain is a breakout above $12 or breakdown below $9. ⚠️ Disclaimer: This is not financial advice. Options trading
DBS at $57.63 and 4.59% Yield | SGX Daily Pulse 07 Apr 2026 | 🦖EP1532
DBS at $57.63 and 4.59% Yield | SGX Daily Pulse 07 Apr 2026 | 🦖EP1532The STI is flirting with 5,000 because the market sees recovery, but my spreadsheet sees S$178m of Air India losses, 38.7% gearing at “infrastructure” trusts, and US REITs sitting at 45.0% leverage one bad valuation away from a cash call. When DBS prints a 4.59% yield, SIA is loved for load factors, and Del Monte is still trading with negative US$618m equity plus an auditor disclaimer, I cannot pretend these are harmless “income” positions in a CPF or SRS account. My stance is simple: if the cash flow is funding someone else’s restructuring, it has no business being labelled retirement‑grade.In a 5,000‑point STI world, the benchmark is not your neighbour’s portfolio, it is the 1.37–1.46% Singapore T‑Bill and a hard 3.2% F
The question cuts to the core: is this a blip, or a regime shift? --- 1. JPM’s call: extreme, but not random The ~$145 target implies: Tesla trades like a normal auto company, not a tech platform Margins compress + growth slows materially AI/robotaxi premium gets discounted That is a full de-rating thesis, not just a bad quarter. --- 2. What the Q1 miss is really signalling The numbers matter less than the pattern: Inventory +50k units → supply > demand Deliveries miss despite production strength Price cuts already exhausted in many regions This is not just logistics noise. It suggests: > Demand elasticity is weakening at current price points --- 3. The real debate: two Teslas Bull case (what market still prices) Not a car company, but an AI + autonomy platform Robotaxi, Optimus, FSD
$INCANNEX HEALTHCARE LTD(IXHL)$ IXHL is one of the clearest examples of why small-cap biotech stocks can destroy investor trust. The biggest problem is dilution risk. In March 2026, Incannex announced a US$10 million registered direct offering priced at US$5.00 per share with accompanying warrants, and it also expanded its sales-agreement capacity by another US$50 million of common stock issuance. For existing shareholders, that creates a heavy overhang and makes it hard to feel protected. The business is still highly speculative. In its quarterly reporting, the company said it generated no revenue for the December 2025 quarter and does not expect material revenue unless and until its drug candidates are approved. It also reported continuing oper
$Plug Power(PLUG)$ $10 Target Price Positive Catalysts for PLUG Growth 1. Major Electrolyzer Project Win with Hy2gen: Event: On April 2, 2026, PLUG was selected to supply a 275 MW Geneco electrolyzer system to Hy2gen's Courant decarbonized ammonia project in Canada. Catalyst Impact: This is a significant, large-scale industrial project that validates PLUG's technology in the green hydrogen space. It represents substantial future
I still remember last April clearly — when tariff headlines triggered a waterfall selloff. What I learned is simple: panic-selling is usually the worst move. When $S&P 500(.SPX)$ and $NASDAQ(.IXIC)$ crashed, the rebound came just days later. That taught me to stay disciplined and not get shaken out at the bottom. Going into tonight, I’m staying cautious. With $FUT:WTI Crude Oil - main 2604(CLmain)$ already elevated, the setup feels very binary. I’m not chasing — just holding some cash and keeping hedges on. For me, capital preservation matters more than trying to perfectly call the move. Liquidity and flexibility are my priority here. I think the mark
I find both strategies interesting, but I wouldn’t take the “100% win rate” literally. CNBC’s “Markets in Turmoil” makes sense psychologically — extreme fear often marks a bottom — but it’s based on limited historical context. Similarly, the $S&P 500(.SPX)$ being higher a year later reflects long-term upward bias, not a guaranteed signal. The $Cboe Volatility Index(VIX)$ 35/15 rule feels more practical since it measures market sentiment. High VIX shows panic, low VIX shows complacency, but I see it as a guideline rather than a strict rule — markets can stay fearful or calm longer than expected. I wouldn’t rely on t